Feb 18 2025 55 mins 3
Picture a 72-year-old farmer in Idaho who has been diagnosed with skin cancer. He's about to start a tough regime of chemotherapy. The kind of toxic drugs that have been used to blast such cancers for 40 odd years. It's the only way his doctor knows to treat the cancer. It's possible the treatment could work. But it's also possible the treatment could kill him. But within 24 hours of testing and diagnosis, the doctor gets a knock at the door from a representative from a drug company. They're offering an alternative treatment so precise that it has been tailored to match the profile of the patient's very DNA. And they've arrived at the door of that clinic with that treatment because a company in Northern Ireland has crunched the data from the testing centre and discovered there's a patient there that could benefit. This is precision medicine in action and it's almost the stuff of science fiction, but it's the daily business of Ryan Keeling and his company Diaceutics. Ryan tells the story of how the company began life in his uncle's basement, but is now publicly listed and working with the world's biggest pharmaceutical companies at the cutting edge of diagnostics and modern medicine.
Hosted on Acast. See acast.com/privacy for more information.
